Even though P53 is commonly recognized as a tumor suppressor, it was recently reported to act as a critical mediator of chemotherapy-drug-induced cancer stem cell activation via the WNT/β-catenin signaling pathway [20]. This evidence concerns the gene TP53 and neoplasm.